Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Receivables (2016 - 2025)

Historic Receivables for Outlook Therapeutics (OTLK) over the last 3 years, with Q4 2025 value amounting to $114609.0.

  • Outlook Therapeutics' Receivables changed N/A to $114609.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $114609.0, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2025, which is N/A changed from last year.
  • Outlook Therapeutics' Receivables amounted to $114609.0 in Q4 2025.
  • Outlook Therapeutics' Receivables' 5-year high stood at $1.8 million during Q2 2025, with a 5-year trough of $114609.0 in Q4 2025.